Pharma's Almanac

3491 Articles Available

1 146

Water for Injection

Membrane-Based Reverse Osmosis Systems for WFI Production

PAO-NI-0719-CL-001

Clinical Data

Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy (DMD)

PR-M07-19-NI-017

FDA Approval

Pfizer Receives U.S. FDA Approval for Its Oncology Biosimilar, ZIRABEV™ (bevacizumab-bvzr)

PR-M07-19-NI-015

Phase II

Iovance Biotherapeutics Provides Cervical Cancer Program Updates Following End of Phase 2 Meeting with U.S. Food and Drug Administration (FDA)

PR-M07-19-NI-016

Partnership

Amicus Therapeutics and Catalent Biologics Enter Strategic Partnership for Gene Therapy Development and Manufacturing

PR-M07-19-NI-014

M&A

Lonza to Acquire Sterile Fill and Finish Facility from Novartis

PR-M07-19-NI-010

Announcement

Bayer Supervisory Board Takes Action to Address the Glyphosate Litigation and Welcomes the Appointment of Ken Feinberg as Mediator

PR-M07-19-NI-009

FDA

FDA Warns Patients and Healthcare Providers About Potential Cybersecurity Concerns with Certain Medtronic Insulin Pumps

PR-M07-19-NI-012

CSR

Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program

PR-M07-19-NI-008

Funding

Esperion and Oberland Capital Announce $200 Million Funding Agreement

PR-M07-19-NI-007

Leadership

Carrick Therapeutics Announces Plan to Establish US Operations and Appointment of Tim Pearson as CEO

PR-M07-19-NI-006

FDA Approval

Dova Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for DOPTELET® (avatrombopag) for Treatment of Chronic Immune Thrombocytopenia (ITP)

PR-M07-19-NI-005

Leadership

Xencor Announces the Planned Retirement of Chief Medical Officer Paul Foster, M.D.

PR-M07-19-NI-006

M&A

FLAMMA Acquires Teva’s Philadelphia cGMP Facility Marking Entry into the US Marketplace with Labs & Pilot Plant

PR-M07-19-NI-013

Expansion

Sartorius Starts up Operations at Expanded Site in Puerto Rico

PR-M07-19-NI-007

NDA

Zosano Pharma Completes Site Qualification Batches at Contract Manufacturing Organization as it Prepares for NDA Submission of Qtrypta™

PR-M07-19-NI-008

Operational Review

ImmunoGen Announces Completion of Operational Review

PR-M07-19-NI-005

T-Cell

Promoting T-Cell Survival

PAO-M07-19-NI-008

3D Printing

Printing 3D Lungs Using Food Dyes

PAO-M07-19-NI-007

Drug Development

Spotlight on P2X3 Antagonists

PAO-M07-19-NI-006

Priority Review

Melinta’s Antibiotic Baxdela Gets Priority Review from FDA for CAPB

PAO-M07-19-NI-005

FDA

FDA Considering Drug Designed to Improve Sexual Desire

PAO-M07-19-NI-004

Clinical Trials

FDA Provides Guidance on Increasing Clinical Trial Diversity

PAO-M07-19-NI-003

Opioid Crisis

Analysis of Medicare Prescriptions Uncovers Role Surgeons Played in Opioid Crisis

PAO-M07-19-NI-002

1 146

»